ALC vs ALNY

Alcon Inc. (ALC) exhibits a weak Piotroski F-Score of 4/9, indicating marginal financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite solid revenue growth and strong gross margins, earnings are contracting year-over-year, and the stock trades at a high valuation (P/E 38.60 vs. sector average 212.00) with a weak technical trend. Analysts recommend a 'buy' with a $91.80 target, implying 14% upside, but this is at odds with deteriorating profitability and low insider sentiment. The Graham Number of $45.87 suggests significant overvaluation, though sector dynamics and growth expectations may justify some premium.

ALNY's Piotroski F-Score of 4/9 indicates weak financial health, falling into the 'Weak' range, which raises concerns despite strong profitability and growth metrics. The company trades at a premium valuation with a P/E of 135.09 and Price/Sales of 11.19, significantly above sector averages, suggesting high growth expectations are already priced in. Insider selling activity totaling $11.62M over six months signals bearish sentiment from within the company, particularly from senior officers. While revenue growth is impressive at 84.9% YoY and ROE is exceptionally high at 73.28%, the lack of earnings consistency and negative free cash flow (implied by missing data) undermine sustainability. The Graham Number of $17.64 and intrinsic value of $16.24 are far below the current price of $313.41, indicating severe overvaluation unless future growth materializes at extraordinary rates.